CCR2 (Plozalizumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7607789

The Humanized Monoclonal anti-CCR2 (Plozalizumab Biosimilar) antibody has been validated for FACS. It is suitable to detect CCR2 (Plozalizumab Biosimilar) in samples from Human.

Quick Overview for CCR2 (Plozalizumab Biosimilar) antibody (Biotin) (ABIN7607789)

Target: CCR2 (Plozalizumab Biosimilar)

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CCR2 (Plozalizumab Biosimilar) antibody is conjugated to Biotin

Application: Flow Cytometry (FACS)

Product Details anti-CCR2 (Plozalizumab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-CCR2(plozalizumab biosimilar) mAb

Isotype: IgG1

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Target Details for CCR2 (Plozalizumab Biosimilar)

Target: CCR2 (Plozalizumab Biosimilar)

Alternative Name: plozalizumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:CC-CKR-2,CCR2A,CCR2B,CD192,CKR2,CKR2A,CKR2B,CMKBR2,MCP-1-R
Synonyms Antibody:MLN-1202, MLN1202, anti-CCR2, hu1D9